RO 240238
Latest Information Update: 24 Jan 2007
Price :
$50 *
At a glance
- Originator Roche
- Class Anti-ischaemics; Antiasthmatics
- Mechanism of Action Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma